Literature DB >> 1659587

Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.

R Q Hintzen1, R A van Lier, K C Kuijpers, P A Baars, W Schaasberg, C J Lucas, C H Polman.   

Abstract

The expression of the T cell membrane molecule CD27--a molecule that has recently been shown to belong to the nerve growth factor receptor superfamily--is strongly increased after activation of T lymphocytes via the T cell receptor/CD3 complex. In addition, activated cells release a 28-32 kDa soluble form of CD27 in their supernatant which can also be detected in serum and urine of healthy individuals. In this study we show that levels of soluble (s) CD27 are significantly elevated in cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients and of patients and of suffering from other inflammatory neurological diseases (OIND), whereas increased levels of sCD25 (soluble interleukin-2 receptor) were only found in CSF of patients with OIND. In MS patients, a significant correlation was found between CSF sCD27 titer and IgG index.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659587     DOI: 10.1016/0165-5728(91)90175-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers.

Authors:  Qing Lan; Luoping Zhang; Xiaojiang Tang; Min Shen; Martyn T Smith; Chuangyi Qiu; Yichen Ge; Zhiying Ji; Jun Xiong; Jian He; Boris Reiss; Zhenyue Hao; Songwang Liu; Yuxuan Xie; Weihong Guo; Mark P Purdue; Noe Galvan; Kerry X Xin; Wei Hu; Laura E Beane Freeman; Aaron E Blair; Laiyu Li; Nathaniel Rothman; Roel Vermeulen; Hanlin Huang
Journal:  Carcinogenesis       Date:  2010-06-07       Impact factor: 4.944

2.  CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein.

Authors:  K V Prasad; Z Ao; Y Yoon; M X Wu; M Rizk; S Jacquot; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 3.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course.

Authors:  A J Swaak; R Q Hintzen; V Huysen; H G van den Brink; J T Smeenk
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

Review 5.  Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.

Authors:  Alexander Baraniskin; Roland Schroers
Journal:  CNS Oncol       Date:  2014-01

6.  Crystal structure of CD27 in complex with a neutralizing noncompeting antibody.

Authors:  Alexey Teplyakov; Galina Obmolova; Thomas J Malia; Gary L Gilliland
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-04-26       Impact factor: 1.056

Review 7.  Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.

Authors:  David Baker; Monica Marta; Gareth Pryce; Gavin Giovannoni; Klaus Schmierer
Journal:  EBioMedicine       Date:  2017-01-31       Impact factor: 8.143

8.  Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis.

Authors:  Zara A Ioannides; Peter A Csurhes; Andrew Swayne; Philippe Foubert; Blake T Aftab; Michael P Pender
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-06-03

9.  Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.

Authors:  Edwin Bremer
Journal:  ISRN Oncol       Date:  2013-06-11

10.  T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.

Authors:  Yu Yi M Wong; Roos M van der Vuurst de Vries; E Daniëlle van Pelt; Immy A Ketelslegers; Marie-José Melief; Annet F Wierenga; Coriene E Catsman-Berrevoets; Rinze F Neuteboom; Rogier Q Hintzen
Journal:  Mult Scler       Date:  2018-07-18       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.